IHS Chemical Week

Merck to invest €80 million to build pharma facility in China

12:18 PM MST | November 15, 2013

Merck KGaA says its biopharmaceutical division Merck Serono (Darmstadt, Germany), will invest €80 million ($107 million) to build a new pharmaceutical manufacturing facility in the Nantong Economical Technological Development Area in the Greater Shanghai region in China. The facility will focus on the bulk production and packaging of Glucophage, Concor and Euthyrox, Merck’s brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders, respectively. Construction on the facility is scheduled to start in 2014 and will be completed in 2016...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 

Username:
Password:

Forgot your user ID or password? Click here to have it sent to you.













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa